Insulin For Life USA Inc (EIN 460771608) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2012

Legal Domicile

Principal Officer

Dr Mark Atkinson

Phone

3523278649

Tax Period

2024-01-01 to 2024-12-31

Insulin For Life USA Inc, founded in 2012, is a community nonprofit in the International Affairs sector that reported $8.2M in total revenue in fiscal year 2024. Revenue decreased 6% compared to the prior year.

Mission

See Sch O

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $8,178,327

Program Service Revenue $0

Investment Income $42,236

Other Revenue $0

TOTAL REVENUE $8,220,563

Expense Breakdown

Grants Paid $8,060,338

Salaries & Benefits $191,113

Fundraising Expenses $0

Program Expenses $8,331,344

Other Expenses $188,381

TOTAL EXPENSES $8,439,832

Year-over-Year Comparison

	2024	2023	Change
Revenue	$8,220,563	$8,725,534	-0.1%
Expenses	$8,439,832	$11,114,002	-0.2%
Net Income	$-219,269	$-2,388,468	-0.9%

Key Indicators

✓ Grants to Organizations ✓ Grants to Individuals ✗ Lobbying ✗ Political Activity ✓ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

⚠ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
Dr Mark Atkinson	President	1.00	Officer Director	$0	$0	$0
Margery Perry	Vice President	1.00	Officer Director	$0	$0	$0
Howard Steinberg	Director	0.25	Director	$0	$0	$0
Henry Anhalt	Director	0.25	Director	$0	$0	$0
Howard Halligan	Secretary-Treasurer	0.25	Officer Director	$0	$0	$0
Moira McCarthy	Director	0.25	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	No data	No data	No data	No data
2024	$8,220,563	$8,439,832	$6,482,955	$-219,269
2023	$8,725,534	$11,114,002	$6,702,497	$-2,388,468
2022	$9,286,572	$7,416,026	$9,085,010	$1,870,546
2021	$8,108,896	$6,974,852	$7,217,189	$1,134,044
2020	$9,773,202	$11,837,181	$6,089,138	$-2,063,979
2019	$6,658,756	$5,314,066	$8,150,214	$1,344,690
2018	$5,816,398	$5,525,588	$4,185,508	$290,810

Insulin For Life USA Inc